Instructions for Ekurochol (Ursodeoxycholic acid) capsules
Description Ursodeoxycholic acid:
Hard gelatin capsules No0. The body of white color is opaque, the lid of light gray color is opaque. The contents of the capsules are a mixture of powder and granules of white or almost white color. It is allowed to compact the contents of the capsules into lumps that are easily destroyed by pressure.
Composition
Active ingredient: ursodeoxycholic acid - 250.00 mg.
Excipients:
corn starch - 73.00 mg,
silicon dioxide colloidal - 5.00 mg,
magnesium stearate - 2.00 mg.
The composition of the capsule lid:
titanium dioxide - 2.0000%,
gelatin - up to 100%.
Composition of the capsule body:
titanium dioxide - 2.0000%,
gelatin - up to 100%.
Use in renal dysfunction
Contraindicated in severe renal dysfunction.
Use in case of impaired liver function
Contraindicated in cirrhosis of the liver in the stage of vascular and parenchymal decompensation and / or pronounced activity.
- Nosology Ursodeoxycholic acid (ICD codes)
- B15
- Acute hepatitis A
- B16
- Acute hepatitis B
- B17
- Other acute viral hepatitis
- E84
- Cystic fibrosis
- K21.0
- Gastroesophageal reflux with esophagitis
- K29
- Gastritis and duodenitis
- K70
- Alcoholic liver disease
- K71
- Toxic liver damage
- K73.2
- Chronic active hepatitis not classified under other headings
- K74.3
- Primary biliary cirrhosis
- K80
- Cholelithiasis [cholelithiasis] (including hepatic colic)
- K81.1
- Chronic cholecystitis
- K83.9
- Biliary tract disease unspecified
- Q44.2
- Atresia of the bile ducts
- Y42.4
- Oral contraceptives
- Y43.1
- Antitumor antimetabolites
- Y43.2
- Natural antitumor drugs
- Y43.3
- Other anticancer drugs
- Z94.4
- Presence of a transplanted liver
Pharmacotherapeutic group: hepatoprotective agent
ATX Code: A05AA02
Pharmacodynamics Ursodeoxycholic acid:
Hepatoprotective agent, has a choleretic effect. Reduces the synthesis of cholesterol in the liver, its absorption in the intestine and concentration in bile, increases the solubility of cholesterol in the biliary system, stimulates the formation and excretion of bile.
Testimony Ursodeoxycholic acid:
- Dissolution of small and medium cholesterol stones with a functioning gallbladder;
- prevention of recurrence of stone formation after cholecystectomy;
- biliary reflux gastritis and reflux esophagitis;
- primary biliary cirrhosis of the liver in the absence of signs of decompensation (symptomatic treatment);
- chronic hepatitis of various genesis;
- acute hepatitis;
- primary sclerosing cholangitis;
- cystic fibrosis of the liver;
- toxic (including medicinal) liver damage;
- non-alcoholic steatohepatitis;
- alcoholic liver disease;
- dyskinesia of the biliary tract.
How to take, course of administration and dosage Ursodeoxycholic acid:
Inwards. Children and adults weighing less than 34 kg are recommended to use the drug in the form of a suspension.
